Targeted Therapy and Molecular Diagnostics

Targeted Therapy and Molecular Diagnostics involve the use of specific drugs or treatments that target the molecular and genetic changes driving cancer growth, rather than affecting all rapidly dividing cells like traditional chemotherapy. Molecular diagnostics play a key role by analyzing genetic mutations, proteins, and other biomarkers in tumors to identify these specific targets. This allows for the development of targeted therapies that focus on blocking or modifying the action of cancer-causing molecules, improving treatment efficacy and reducing side effects. These approaches enable more personalized, precise cancer treatments that are tailored to the individual characteristics of a patient's tumor, leading to better outcomes.

    Related Conference of Targeted Therapy and Molecular Diagnostics

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Targeted Therapy and Molecular Diagnostics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in